Through insulin-induced PD-L1 expression, pancreatic cancer cells suppress proliferation of CD8+ T-cells underscoring the potential of insulin to confer immune evasion through this immune checkpoint regulator. This evidence concerns the gene INS and pancreatic neoplasm.